Safety, pharmacokinetics and efficacy of IMCgp100, a first-in-class soluble TCR-antiCD3 bispecific t cell redirector with solid tumour activity: Results from the FIH study in melanoma
Middleton MR. et al, (2016), JOURNAL OF CLINICAL ONCOLOGY, 34
An Adaptive Study to Determine the Optimal Dose of the Tablet Formulation of the PARP Inhibitor Olaparib
Mateo J. et al, (2016), Targeted Oncology
Clinical Application of Poly(ADP-Ribose) Polymerase Inhibitors in High-Grade Serous Ovarian Cancer.
Parkes EE. and Kennedy RD., (2016), Oncologist, 21, 586 - 593
PREFERENCE-BASED UTILITIES FOR ADJUVANT MELANOMA IN THE UNITED KINGDOM AND AUSTRALIA
Middleton M. et al, (2016), VALUE IN HEALTH, 19, A157 - A157
Results of a large retrospective analysis of the effect of intended dose intensity of R-CHOP on outcome in a cohort of consecutive, unselected elderly patients with de novo diffuse large B cell lymphoma.
Eyre TA. et al, (2016), Br J Haematol, 173, 487 - 491
Results of a large retrospective analysis of the effect of intended dose intensity of R-CHOP on outcome in a cohort of consecutive, unselected elderly patients with de novo diffuse large B cell lymphoma
Eyre TA. et al, (2016), BRITISH JOURNAL OF HAEMATOLOGY, 173, 487 - 491
TREATMENT PATTERNS AMONG ADVANCED MELANOMA PATIENTS IN EUROPE
Sheahan K. et al, (2016), VALUE IN HEALTH, 19, A162 - A162
Durable response of spinal chordoma to combined inhibition of IGF-1R and EGFR
Macaulay V. et al, (2016), Frontiers in Oncology
A BRCA1 deficient, NFκB driven immune signal predicts good outcome in triple negative breast cancer.
Buckley NE. et al, (2016), Oncotarget, 7, 19884 - 19896
Single-cell profiling of human megakaryocyte-erythroid progenitors identifies distinct megakaryocyte and erythroid differentiation pathways
Psaila B. et al, (2016), Genome Biology
Differential clonal evolution in oesophageal cancers in response to neo-adjuvant chemotherapy.
Findlay JM. et al, (2016), Nature communications, 7, 11111 - 11111
Single cell RNA sequencing reveals molecular and functional platelet bias of aged hematopoietic stem cells
Nerlov C. et al, (2016), Nature Communications
The RNA-binding protein LARP1 is a post-transcriptional regulator of survival and tumorigenesis in ovarian cancer.
Hopkins TG. et al, (2016), Nucleic Acids Res, 44, 1227 - 1246
Phase I Dose Escalation Study of Linsitinib (OSI-906) and Erlotinib in Patients with Advanced Solid Tumors
Macaulay V., (2016), Clinical Cancer Research
A dynamic niche provides Kit ligand in a stage-specific manner to the earliest thymocyte progenitors
Buono M. et al, (2016), Nature Cell Biology
A phase Ib study of NUC1031 and carboplatin for patients with recurrent ovarian cancer.
Blagden SP. et al, (2016), JOURNAL OF CLINICAL ONCOLOGY, 34
Antiangiogenic Resistance and Cancer Metabolism: Opportunities for Synthetic Lethality.
Lord S. et al, (2016), Curr Drug Targets, 17, 1714 - 1727
Genetic Biomarkers of Barrett's Esophagus Susceptibility and Progression to Dysplasia and Cancer: A Systematic Review and Meta-Analysis.
Findlay JM. et al, (2016), Dig Dis Sci, 61, 25 - 38